Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer (PLoS ONE (2011) 6:4 (e18434) DOI: 10.1371/journal.pone.0018434);Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Wang, Feng ^a   Xu, Ling ^b   Guo, Chuanyong ^b   Ke, Aiwu ^b   Hu, Guoyong ^b   Xu, Xuanfu ^b   Mo, Wenhui ^b   Yang, Lijuan ^a   Huang, Yinshi ^b   He, Shanshan ^b   Wang, Xingpeng ^a,b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GLI1; GLI1 PROTEIN, HUMAN; LECTIN; MESSENGER RNA; REG4 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROMOTER REGION; PROTEIN EXPRESSION; REGIV GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; PANCREAS TUMOR; PROTEIN BINDING; TUMOR CELL LINE; TUMOR GENE;

ERINACEIDAE;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 79954522869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0298197     Document Type: Erratum

References (44)

1. Bardeesy N, DePinho RA, (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics. CA Cancer J Clin 58: 71-96.
3. Herszényi L, Tulassay Z, (2010) Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14: 249-258.
4. Morris JP 4th, Wang SC, Hebrok M, (2010) KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nature Reviews Cancer 10: 683-695.
5. Klein WM, Hruban RH, Klein-Szanto AJ, Wilentz RE, (2002) Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod Pathol 15: 441-447.
6. Kim SK, Hebrok M, (2001) Intercellular signals regulating pancreas development and function. Genes Dev 15: 111-127.
7. Prasad NB, Biankin AV, Fukushima N, Maitra A, Dhara S, et al. (2005) Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 65: 1619-1626.
8. Nüsslein-Volhard C, Wieschaus E, (1980) Mutations affecting segment number and polarity in Drosophila. Nature 287: 795-801.
9. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, et al. (1996) Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383: 407-413.
10. Hebrok M, (2003) Hedgehog signaling in pancreas development. Mech Dev 120: 45-57.
11. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, et al. (2003) Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422: 313-317.
12. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851.
13. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856.
14. Morton JP, Mongeau ME, Klimstra DS, Morris JP, Lee YC, et al. (2007) Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A 104: 5103-5108.
15. Ingham PW, McMahon AP, (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15: 3059-3087.
16. Dai P, Akimaru H, Tanaka Y, Maekawa T, Nakafuku M, et al. (1999) Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3. J Biol Chem 274: 8143-8152.
17. Lee J, Platt KA, Censullo P, Ruiz i Altaba A, (1997) Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 124: 2537-2552.
18. Wang B, Fallon JF, Beachy PA, (2000) Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100: 423-434.
19. Aza-Blanc P, Lin HY, Ruiz i Altaba A, Kornberg TB, Expression of the vertebrate Gli proteins in Drosophila reveals a distribution of activator and repressor activities. Development 2000;127: 4293-4301.
20. Zhang YW, Ding LS, Lai MD, (2003) Reg gene family and human diseases. World J Gastroenterol 9: 2635-2641.
21. Bishnupuri KS, Luo Q, Sainathan SK, Kikuchi K, Sureban SM, et al. (2010) Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 138: 616-626.
22. Sekikawa A, Fukui H, Fujii S, Takeda J, Nanakin A, et al. (2005) REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 128: 642-653.
23. Kuniyasu H, Oue N, Sasahira T, Yi L, Moriwaka Y, et al. (2009) Reg IV enhances peritoneal metastasis in gastric carcinomas. Cell Prolif 42: 110-121.
24. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, et al. (2004) Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405.
25. Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, et al. (2003) Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 103: 185-193.
26. Zhang Y, Lai M, Lv B, Gu X, Wang H, et al. (2003) Overexpression of Reg IV in colorectal adenoma. Cancer Lett 200: 69-76.
27. Takehara A, Eguchi H, Ohigashi H, Ishikawa O, Kasugai T, et al. (2006) Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci 97: 1191-1197.
28. Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, et al. (2010) Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol 45: 52-59.
29. Nanakin A, Fukui H, Fujii S, Sekikawa A, Kanda N, et al. (2007) Expression of the REG IV gene in ulcerative colitis. Lab Invest 87: 304-314.
30. Legoffic A, Calvo E, Cano C, Folch-Puy E, Barthet M, et al. (2009) The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target. PLoS One 4: e7495.
31. Ni Z, Kim ED, Ha M, Lackey E, Liu J, et al. (2009) Altered circadian rhythms regulate growth vigour in hybrids and allopolyploids. Nature 457: 327-331.
32. Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, et al. (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23: 24-36.
33. Feldmann G, Fendrich V, McGovern K, Bedja D, Bisht S, et al. (2008) An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther 7: 2725-2735.
34. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, et al. (2007) Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187-2196.
35. Nagai S, Nakamura M, Yanai K, Wada J, Akiyoshi T, et al. (2008) Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation. Cancer Sci 99: 1377-1384.
36. Katoh Y, Katoh M, (2009) Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation. Curr Mol Med 9: 873-886.
37. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, et al. (2005) Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 207: 185-198.
38. Li XH, Zheng Y, Zheng HC, Takahashi H, Yang XH, et al. (2010) REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study. Histol Histopathol 25: 473-484.
39. Li FY, Ren XB, Xu EP, Huang Q, Sheng HQ, et al. (2010) RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor. J Zhejiang Univ Sci B 11: 258-66.
40. Eguchi H, Ishikawa O, Ohigashi H, Takahashi H, Yano M, et al. (2009) Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer. Pancreas 38: 791-798.
41. Tamura H, Ohtsuka M, Washiro M, Kimura F, Shimizu H, et al. (2009) Reg IV expression and clinicopathologic features of gallbladder carcinoma. Human Pathology 40: 1686-1692.
42. Kinzler KW, Vogelstein B, (1990) The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol Cell Biol 10: 634-642.
43. Mitani Y, Oue N, Matsumura S, Yoshida K, Noguchi T, et al. (2007) Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 26: 4383-4393.
44. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, et al. (2006) Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 130: 137-149.